Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06730334

Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

A Single Centre Prospective Cohort Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.

Conditions

Timeline

Start date
2023-09-01
Primary completion
2026-09-01
Completion
2028-06-01
First posted
2024-12-12
Last updated
2024-12-20

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06730334. Inclusion in this directory is not an endorsement.

Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasono (NCT06730334) · Clinical Trials Directory